Drug Approval | April 18, 2022
Zydus Lifesciences receives final approval from USFDA for Cyanocobalamin Injection
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
The company also plans to expand the facility
A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Both companies have been selected for stand-by production by German government
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
The expansion positions Cambrex with the largest and most advanced API facility in the United States
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Subscribe To Our Newsletter & Stay Updated
